| Pharmaceutical active ingredients: |
| Lovastatin |
| Available forms, composition and doses of Monacolin K: |
| N / A |
| Monacolin K medical category: |
| Human:Dyslipidaemic agentsHMG-COA reductase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C10AA02 - Lovastatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mole Death | Strychnine | Unidentified Pharmaceutical Company |
| Molinal | Phenobarbital | Unidentified Pharmaceutical Company |
| Mollinox | Methaqualone | Unidentified Pharmaceutical Company |
| Molol | Mineral Oil | Unidentified Pharmaceutical Company |
| Molycor-R | Norfenefrine | Unidentified Pharmaceutical Company |
| Monafuracin | Nitrofurazone | Unidentified Pharmaceutical Company |
| Monafuracis | Nitrofurazone | Unidentified Pharmaceutical Company |
| Monagyl | Metronidazole | Unidentified Pharmaceutical Company |
| Monakolin K | Lovastatin | Unidentified Pharmaceutical Company |
| Monamine | Meclizine | Unidentified Pharmaceutical Company |